Keratin 8 variants are associated with cryptogenic hepatitis

Area of Science:

• Hepatology
• Molecular Biology
• Genetics

Background:

• Keratins 8 and 18 (K8/K18) are intermediate filament proteins in hepatocytes.
• Mutations in K8/K18 genes are linked to liver injury in murine models and associated with human liver diseases.
• The role of K8/K18 variants in cryptogenic hepatitis, a liver disease of unknown cause, remains largely unexplored.

Purpose of the Study:

• To investigate the association between K8 variants and cryptogenic hepatitis in a German patient cohort.
• To compare the frequency of K8 variants in cryptogenic hepatitis patients versus healthy controls.

Main Methods:

• Genomic DNA was extracted from liver biopsies of cryptogenic hepatitis patients and peripheral blood of healthy donors.
• Polymerase chain reaction (PCR) amplification and direct DNA sequencing were used to analyze K8 variants.
• Statistical analysis was performed to compare variant frequencies between groups.

Main Results:

• Eight novel heterozygous or homozygous amino acid-altering K8 variants were identified in 8.1% of cryptogenic hepatitis patients (5/62).
• No novel K8 variants were found in the control group (0/67), with statistical significance (P=0.02).
• Previously described K8 variants (p.G62C, p.R341H) showed similar frequencies in both patients and controls, indicating they are polymorphisms.

Conclusions:

• Previously undescribed K8 variants are associated with cryptogenic hepatitis in the studied German cohort.
• These novel K8 variants may predispose individuals to the development of cryptogenic hepatitis.
• Further research is warranted to elucidate the functional impact of these variants on liver disease progression.